Search

Displaying results 191 - 200 of 3364 in total
  1. Drug

    Atazanavir

    go.drugbank.com/drugs/DB01072
    ApprovedInvestigational

    Food and Drug Administration (FDA) approved atazanavir on June 20, 2003.

    Products: VIRAZAN 200 MG, ATAZANAVIR 200 MG
  2. Drug

    Rifaximin

    go.drugbank.com/drugs/DB01220
    ApprovedInvestigational

    Rifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that the drug will not pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics. It has multiple in...

    Products: IFAXIM 200 MG., RIFABAC 200 MG TABLETAS
  3. Drug

    Hydroxychloroquine

    go.drugbank.com/drugs/DB01611
    ApprovedInvestigational

    [A192132] **The FDA emergency use authorization for hydroxychloroquine and [chloroquine] in the treatment of COVID-19 was revoked on 15 June 2020.

    Products: ARTROQUIN 200 MG, HALOXIN TABLET 200 mg
  4. Drug

    Ginkgo biloba

    go.drugbank.com/drugs/DB01381
    ApprovedInvestigationalNutraceutical

    Ginkgo biloba extract contains a group of terpene lactones (notably, ginkgolides and diterpenes) and ginkgo flavone glycosides (notably, ginkgetin, bilobetin, and sciadopitysin) that have antioxidant and vasoactive properties. Most of th...

    Mixtures: MEGINGO 20/50 MG EFERVESAN TABLET, 100 ADET, MEGINGO 20/80 MG EFERVESAN TABLET, 100 ADETCategories: Complex Mixtures
  5. Drug

    Cupric sulfate

    go.drugbank.com/drugs/DB06778
    Approved

    The average daily intake of copper in the USA is approximately 1 mg Cu with the diet being a primary source [A32221]. … The anhydrous salt is created by heating the hydrate to 150 °C (300 °F). Cupric sulfate is used primarily for agricultural purposes, as a pesticide, germicide, feed additive, and soil additive.

    Mixtures: M T E 4 Concentrate Inj, OB Complete 400Categories: copper sulfate
  6. Drug

    Avelumab

    go.drugbank.com/drugs/DB11945
    ApprovedInvestigational

    [A261496] Avelumab was first approved by the FDA on March 23, 2017.

    Products: BAVENCIO 200 mg/10mL concentrate for solution for infusion, BAVENCIO 200 MG/10 ML IV İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN KONSANTRE, 1 FLAKON
  7. Drug

    Enoxaparin

    go.drugbank.com/drugs/DB01225
    ApprovedInvestigational

    [L31393] Enoxaparin markedly reduces the incidence of venous thromboembolism in hospitalized patients when compared to unfractionated [heparin], without increasing the risk of serious bleeding.

    Mixtures: ENOXAPARINA SODICA 40 MG JERINGAS PRELLENADASProducts: KLEXANE 20 MG 0.2 ML, ENOXALOW® 20 MG
  8. Drug

    Cetirizine

    go.drugbank.com/drugs/DB00341
    ApprovedInvestigational

    Cetirizine, also commonly known as Zyrtec, is an orally active second-generation histamine H1 antagonist proven effective in the treatment of various allergic symptoms, such as sneezing, coughing, nasal congestion, hives, and other sympt...

    Mixtures: ACERADOX® GProducts: ZYRTEC 1 MG 200 ML SURUP, ALLERSET 1 MG/ML ŞURUP, 200 ML
  9. Drug

    Aminophylline

    go.drugbank.com/drugs/DB01223
    ApprovedInvestigational

    Aminophylline is a drug combination that contains theophylline and ethylenediamine in a 2:1 ratio. Once in the body, theophylline is released and acts as a phosphodiesterase inhibitor, adenosine receptor blocker, and histone deacetylase ...

    Products: AMINOCARDOL 10 ML 240 MG 100 AMPUL, AMINOFILINA 240 MG / 10 ML.
  10. Drug

    Ichthammol

    go.drugbank.com/drugs/DB11341
    Approved

    Ichthammol is also referred to as ammonium bituminosulfonate or ammonium bituminosulphonate. It is an ammonium salt of dark sulfonated shale oil (bituminous schists) produced via distillation of the oil followed by sulfonation and neutra...

    Products: ICTAMMOLO MARCO VITI, IHTIYOL POMAT, 20 G